Trusted Resources: Evidence & Education
Scientific literature and patient education texts
Ketamine Infusion for Pain Control in Acute Pediatric Sickle Cell Painful Crises
source: Pediatric Emergency Care
year: 2019
authors: Hagedorn JM, Monico EC
summary/abstract:OBJECTIVES:
Sickle cell disease is the most common hemoglobin variant in the world and can present with recurrent vaso-occlusive painful crises. Pain control in these patients is often difficult and requires a multimodal approach. In patients with uncontrolled pain after traditional pain control methods, ketamine infusions have proven beneficial. Unfortunately, no source alone had described ketamine infusions for pediatric sickle cell patients. Our objective was to provide a thorough definitive reference for health care providers regarding the use of ketamine infusion for pain control in pediatric sickle cell painful crises.
METHODS:
Literature review.
RESULTS:
Low-dose ketamine infusions for pediatric patients with sickle cell disease painful crises resulted in improved pain scores and reduced opioid usage.
CONCLUSIONS:
Ketamine infusions have shown promise in assisting physicians in appropriately treating pediatric sickle cell painful crises.
DOI: 10.1097/PEC.0000000000000978
read more full text
Related Content
-
Comparison of the Safety Profile of Sickle Cell Disease Patients Treated with Hydroxycarbamide in Off-Label Versus i...ESCORT-HU (European Sickle Cell Disease ...
-
More Cures for More Patients Through Sickle Cell Research: Courtney Fitzhugh, MDhttps://www.youtube.com/watch?v=OvdpT1Dn...
-
Elliott Vichinsky, MDElliott Vichinsky, MD diagnoses and trea...
-
Joshua Field, MD, MSDr. Joshua Field is an Associate Medical...
-
Cannabinoid receptor-specific mechanisms to alleviate pain in sickle cell anemia via inhibition of mast cell activ...Sickle cell anemia is a manifestation of...
-
Novartis acquires US pharma research firm Selexys PharmaceuticalsSwiss-based pharmaceuticals giant Novart...
-
Long-term opioids may not be best pain management option for all sickle cell patientsSmall study shows some on opioids report...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.